ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

RAUL MARCO BORRULL M.D.

AVE. LUIS MUNOZ MARIN NO. 50 QUADRANGLE MEDICAL CENTER, SUITE 204

Caguas | Puerto Rico | 00725

(787) 743-1507

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,140Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 71

$1.04M Total Retail Price of All Prescriptions

Rank: 10 out of 71

736 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

1% of this provider’s 736 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 8,264 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 34%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
NAMENDA 1,236 1,090 1 2
DONEPEZIL HCL 985 887 2 1
DIVALPROEX SODIUM ER 573 411 3 37
CLOPIDOGREL 378 317 4 19
RANITIDINE HCL 315 236 5 24
PLAVIX 313 264 6 20
FAMOTIDINE 300 211 7 71
GABAPENTIN 296 143 8 3
SIMVASTATIN 296 210 8 13
LEVETIRACETAM 269 106 10 9
LOSARTAN POTASSIUM 268 159 11 52
RISPERIDONE 262 247 12 22
OXCARBAZEPINE 260 142 13 38
ENALAPRIL MALEATE 250 155 14 48
TRAMADOL HCL-ACETAMINOPHEN 220 102 15 11
PRAMIPEXOLE DIHYDROCHLORIDE 192 122 16 8
TOPIRAMATE 189 76 17 29
SYNTHROID 189 147 17 55
ZOLPIDEM TARTRATE 188 123 19 15
LEVOTHYROXINE SODIUM 187 152 20 61
EXELON 181 148 21 6
CARVEDILOL 164 109 22 105
ASPIRIN EC 158 118 23 46
PRIMIDONE 143 99 24 23
TORSEMIDE 135 78 25 111
PRAVASTATIN SODIUM 133 83 26 98
LAMOTRIGINE 121 68 27 21
AMLODIPINE BESYLATE 110 82 28 59
VIMPAT 110 44 28 69
ACETAZOLAMIDE 99 56 30 125
LISINOPRIL 97 46 31 126
ATORVASTATIN CALCIUM 96 61 32 86
NABUMETONE 95 39 33 31
VITAMIN D 91 71 34 127
ZETIA 83 40 35 90
CYMBALTA 83 25 35 16
CILOSTAZOL 73 59 37 133
OMEPRAZOLE 72 37 38 36
STALEVO 100 72 70 38 104
LYRICA 71 26 40 12
CARBIDOPA-LEVODOPA-ENTACAPONE 68 54 41 91
STALEVO 150 68 45 41 101
TAMSULOSIN HCL 66 57 43 116
MIDODRINE HCL 61 40 44 142
AGGRENOX 59 37 45 89
DICLOFENAC POTASSIUM 59 19 45 25
ALENDRONATE SODIUM 55 53 47 117
EVISTA 54 38 48 152
LOSARTAN-HYDROCHLOROTHIAZIDE 51 40 49 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.